IFOSFAMIDE WITH MESNA UROPROTECTION AND ETOPOSIDE - AN EFFECTIVE REGIMEN IN THE TREATMENT OF RECURRENT SARCOMAS AND OTHER TUMORS OF CHILDREN AND YOUNG-ADULTS

被引：269
作者：
MISER, JS
KINSELLA, TJ
TRICHE, TJ
TSOKOS, M
JAROSINSKI, P
FORQUER, R
WESLEY, R
MAGRATH, I
机构：
[1] NCI,PEDIAT BRANCH,BETHESDA,MD 20205
[2] NCI,RADIAT BRANCH,BETHESDA,MD 20205
[3] NCI,BIOSTAT BRANCH,BETHESDA,MD 20205
[4] CLIN CTR,DEPT PHARM,BETHESDA,MD
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 08期
关键词：
D O I：
10.1200/JCO.1987.5.8.1191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1191 / 1198
页数：8
相关论文
共 35 条
[1]  
ANTMAN KH, 1985, CANCER TREAT REP, V69, P499
[2]  
BAUM ES, 1981, CANCER TREAT REP, V65, P815
[3]   IFOSFAMIDE - PHARMACOLOGY, SAFETY AND THERAPEUTIC POTENTIAL [J].
BRADE, WP ;
HERDRICH, K ;
VARINI, M .
CANCER TREATMENT REVIEWS, 1985, 12 (01) :1-47
[4]  
BRADE WP, RECENT EXPERIENCE IF, P5
[5]   THE OXAZAPHOSPHORINES [J].
BROCK, N .
CANCER TREATMENT REVIEWS, 1983, 10 :3-15
[6]   THE DEVELOPMENT OF MESNA FOR REGIONAL DETOXIFICATION [J].
BROCK, N ;
POHL, J .
CANCER TREATMENT REVIEWS, 1983, 10 :33-&
[7]  
BROCK N, 1982, THERAPIEWOCHE, V32, P4977
[8]  
BRUHL P, 1976, INT J CLIN PHARM BI, V14, P29
[9]  
CHARD RL, 1979, CANCER TREAT REP, V63, P1755
[10]  
CHEN OL, 1984, J BIOL CHEM, V259, P13560
1234